We have located links that may give you full text access.
Comparative Study
English Abstract
Journal Article
[Epley and Semont maneuvers in the treatment of bening paroxymal postural vertigo].
Gaceta Médica de México 2000 September
To compare the effectiveness of the 'repositioning' Epley maneuver and the 'liberatory' Semont maneuver in the treatment of benign paroxysmal positional vertigo (BPPV) of the posterior semicircular canal, a prospective study was performed, with 3 months of followup. A consecutive sample of 100 patients was included in two groups (age-and-sex matched) with a similar number of patients with idiopathic BPPV in each group. Group I was treated using the 'repositioning' maneuver and group II, the 'liberatory' maneuver. At weeks 1, 4, and 12 during the study, the proportion of patients without positional nistagmus was identified, and patients gave an evaluation of their subjective improvement (as a percentage). When positional nystagmus was evident, the corresponding maneuver was used again. Sixty percent of the patients were without nystagmus after the single use of any of the maneuvers. At the end of the study, more than 90% of patients were without nystagmus, with a 90% median value of subjective improvement. Patients with idiopathic BPPV showed a similar response to treatment as patients with BPPV associated to other disorders. We conclude that both maneuvers are effective for the treatment of BPPV of the posterior semicircular canal.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app